Mecwins

About:

Mecwins uses its technology to produce sensitive immunoassays for oncology, cardiovascular disease, and infectious diseases.

Website: http://mecwins.com/

Twitter/X: mecwins_biotech

Top Investors: EASME - EU Executive Agency for SMEs, CRB Inverbío

Description:

Mecwins develops technology for nanomechanical sensing and uses its technology to produce sensitive immunoassays for oncology, cardiovascular disease, and infectious diseases. They improve the healthcare of those sections of the population who are particularly at risk.

Total Funding Amount:

4.07M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Madrid, Madrid, Spain

Founded Date:

2008-01-01

Contact Email:

info(AT)mecwins.com

Founders:

Javier Tamayo, Montserrat Calleja

Number of Employees:

11-50

Last Funding Date:

2019-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai